News

Hilleman Laboratories is committed to developing high impact, affordable vaccines for people in developing countries in an innovative and sustainable manner.

EVI and Hilleman Laboratories announce partnership to assess a new vaccine against Shigella

Date: 07/10/2019

EVI and Hilleman Laboratories announce partnership to assess a new vaccine against Shigella

View All